Literature DB >> 31093867

Development of an efficient perfusion-based protocol for whole-organ decellularization of the ovine uterus as a human-sized model and in vivo application of the bioscaffolds.

Seyedeh Sima Daryabari1, Abdol-Mohammad Kajbafzadeh2, Kiarad Fendereski1, Fariba Ghorbani1, Mehrshad Dehnavi1, Minoo Rostami1, Bahram Azizi Garajegayeh3, Seyed Mohammad Tavangar4.   

Abstract

PURPOSE: The main purpose of this investigation was to determine an efficient whole-organ decellularization protocol of a human-sized uterus and evaluate the in vivo properties of the bioscaffold.
METHODS: Twenty-four ovine uteri were included in this investigation and were decellularized by three different protocols (n 6). We performed histopathological and immunohistochemical evaluations, 4,6-diamidino-2-phenylindole (DAPI) staining, DNA quantification, MTT assay, scanning electron microscopy, biomechanical studies, and CT angiography to characterize the scaffolds. The optimized protocol was determined, and patches were grafted into the uterine horns of eight female Wistar rats. The grafts were extracted after 10 days; the opposite horns were harvested to be evaluated as controls.
RESULTS: Protocol III (perfusion with 0.25% and 0.5% SDS solution and preservation in 10% formalin) was determined as the optimized method with efficient removal of the cellular components while preserving the extracellular matrix. Also, the bioscaffolds demonstrated native-like biomechanical, structural, and vascular properties. Histological and immunohistochemical evaluations of the harvested grafts confirmed the biocompatibility and recellularization potential of bioscaffolds. Also, the grafts demonstrated higher positive reaction for CD31 and Ki67 markers compared with the control samples which indicated eminent angiogenesis properties and proliferative capacity of the implanted tissues.
CONCLUSIONS: This investigation introduces an optimized protocol for whole-organ decellularization of the human-sized uterus with native-like characteristics and a prominent potential for regeneration and angiogenesis which could be employed in in vitro and in vivo studies. To the best of our knowledge, this is the first study to report biomechanical properties and angiographic evaluations of a large animal uterine scaffold.

Entities:  

Keywords:  Bioscaffold; Infertility; Regeneration; Tissue engineering; Uterus

Mesh:

Year:  2019        PMID: 31093867      PMCID: PMC6603122          DOI: 10.1007/s10815-019-01463-4

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  26 in total

1.  A well-defined in vitro three-dimensional culture of human endometrium and its applicability to endometrial cancer invasion.

Authors:  Dong Wook Park; Dong Soon Choi; Hee-Sug Ryu; Hyuck Chan Kwon; Hyun Joo; Churl K Min
Journal:  Cancer Lett       Date:  2003-06-10       Impact factor: 8.679

2.  Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart.

Authors:  Harald C Ott; Thomas S Matthiesen; Saik-Kia Goh; Lauren D Black; Stefan M Kren; Theoden I Netoff; Doris A Taylor
Journal:  Nat Med       Date:  2008-01-13       Impact factor: 53.440

3.  Evaluating the efficacy of tissue-engineered human amniotic membrane in the treatment of myocardial infarction.

Authors:  Reza Khorramirouz; Seyedeh M Kameli; Kiarad Fendereski; Seyedeh S Daryabari; Abdol-Mohammad Kajbafzadeh
Journal:  Regen Med       Date:  2019-02-11       Impact factor: 3.806

4.  Allo- and xeno-reassembly of human and rat myometrium from cells and scaffolds.

Authors:  Roger C Young; Gabriela Goloman
Journal:  Tissue Eng Part A       Date:  2013-05-16       Impact factor: 3.845

5.  Towards the development of a bioengineered uterus: comparison of different protocols for rat uterus decellularization.

Authors:  M Hellström; R R El-Akouri; C Sihlbom; B M Olsson; J Lengqvist; H Bäckdahl; B R Johansson; M Olausson; S Sumitran-Holgersson; M Brännström
Journal:  Acta Biomater       Date:  2014-08-25       Impact factor: 8.947

Review 6.  Biomechanics of the human uterus.

Authors:  Kristin M Myers; David Elad
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2017-05-12

Review 7.  Current status of uterus transplantation in primates and issues for clinical application.

Authors:  Iori Kisu; Kouji Banno; Makoto Mihara; Nobuhiko Suganuma; Daisuke Aoki
Journal:  Fertil Steril       Date:  2013-04-01       Impact factor: 7.329

8.  Uterine transplantation FIGO Committee for the Ethical Aspects of Human Reproduction and Women's Health.

Authors:  Jacques Milliez
Journal:  Int J Gynaecol Obstet       Date:  2009-06-05       Impact factor: 3.561

Review 9.  Uterus transplantation and beyond.

Authors:  Mats Brännström
Journal:  J Mater Sci Mater Med       Date:  2017-03-29       Impact factor: 3.896

10.  Application of detergents or high hydrostatic pressure as decellularization processes in uterine tissues and their subsequent effects on in vivo uterine regeneration in murine models.

Authors:  Erna G Santoso; Keita Yoshida; Yasushi Hirota; Masanori Aizawa; Osamu Yoshino; Akio Kishida; Yutaka Osuga; Shigeru Saito; Takashi Ushida; Katsuko S Furukawa
Journal:  PLoS One       Date:  2014-07-24       Impact factor: 3.240

View more
  12 in total

Review 1.  Engineered reproductive tissues.

Authors:  Emma S Gargus; Hunter B Rogers; Kelly E McKinnon; Maxwell E Edmonds; Teresa K Woodruff
Journal:  Nat Biomed Eng       Date:  2020-04-06       Impact factor: 25.671

2.  Effect of NMDA receptor agonist and antagonist on spermatogonial stem cells proliferation in 2- and 3- dimensional culture systems.

Authors:  Amirhessam Eskafi Noghani; Reza Asadpour; Adel Saberivand; Zohreh Mazaheri; Gholamreza Hamidian
Journal:  Mol Biol Rep       Date:  2022-01-09       Impact factor: 2.316

3.  Whole-organ decellularization of the human uterus and in vivo application of the bio-scaffolds in animal models.

Authors:  Seyedeh Sima Daryabari; Kiarad Fendereski; Fariba Ghorbani; Mehrshad Dehnavi; Yazdan Shafikhani; Ara Omranipour; Sam Zeraatian-Nejad Davani; Masoumeh Majidi Zolbin; Seyed Mohammad Tavangar; Abdol-Mohammad Kajbafzadeh
Journal:  J Assist Reprod Genet       Date:  2022-05-05       Impact factor: 3.357

Review 4.  Bioengineering of the Uterus.

Authors:  Yushi Yoshimasa; Tetsuo Maruyama
Journal:  Reprod Sci       Date:  2021-04-07       Impact factor: 3.060

5.  Towards a bioengineered uterus: bioactive sheep uterus scaffolds are effectively recellularized by enzymatic preconditioning.

Authors:  Arvind Manikantan Padma; Laura Carrière; Frida Krokström Karlsson; Edina Sehic; Sara Bandstein; Tom Tristan Tiemann; Mihai Oltean; Min Jong Song; Mats Brännström; Mats Hellström
Journal:  NPJ Regen Med       Date:  2021-05-21

Review 6.  Recent developments in bio-scaffold materials as delivery strategies for therapeutics for endometrium regeneration.

Authors:  X Li; H-F Lv; R Zhao; M-F Ying; A T Samuriwo; Y-Z Zhao
Journal:  Mater Today Bio       Date:  2021-02-25

7.  Towards uterus tissue engineering: a comparative study of sheep uterus decellularisation.

Authors:  T T Tiemann; A M Padma; E Sehic; H Bäckdahl; M Oltean; M J Song; M Brännström; M Hellström
Journal:  Mol Hum Reprod       Date:  2020-03-26       Impact factor: 4.025

Review 8.  Biomaterial strategies for the application of reproductive tissue engineering.

Authors:  Xuemin Liu; Kai Wu; Liang Gao; Liping Wang; Xuetao Shi
Journal:  Bioact Mater       Date:  2021-12-20

Review 9.  Future Challenges and Opportunities of Extracellular Matrix Hydrogels in Female Reproductive Medicine.

Authors:  Emilio Francés-Herrero; Adolfo Rodríguez-Eguren; María Gómez-Álvarez; Lucía de Miguel-Gómez; Hortensia Ferrero; Irene Cervelló
Journal:  Int J Mol Sci       Date:  2022-03-29       Impact factor: 5.923

Review 10.  Decellularization in Tissue Engineering and Regenerative Medicine: Evaluation, Modification, and Application Methods.

Authors:  Afarin Neishabouri; Alireza Soltani Khaboushan; Faezeh Daghigh; Abdol-Mohammad Kajbafzadeh; Masoumeh Majidi Zolbin
Journal:  Front Bioeng Biotechnol       Date:  2022-04-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.